Low tumor PANX1 expression or the loss-of-function P2RX7 allele leads to reduced infiltration of immune cells and poor survival outcomes after adjuvant chemotherapy treatment in CRC patients. This evidence concerns the gene PANX1 and colorectal carcinoma.